Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): Association with clinical severity and phenotype

Allergy and Asthma Proceedings

Volumn 36, Issue 1, 2015, Pages 74-81

  Leonardi, Salvatore ^b   Cuppari, Caterina ^a   Manti, Sara ^a   Filippelli, Martina ^b   Parisi, Giuseppe Fabio ^b   Borgia, Francesco ^a   Briuglia, Silvana ^b   Cannavò, Serafinella Patrizia ^a   Salpietro, Annamaria ^b   Arrigo, Teresa ^b   Salpietro, Carmelo ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; BLOOD LEVEL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRICK TEST; RHINITIS; SCHOOL CHILD; SCORING SYSTEM; BLOOD; CASE CONTROL STUDY; DERMATITIS, ATOPIC; IMMUNOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; SYNDROME;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-23; MALE; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 84919725850     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2015.36.3808     Document Type: Article

References (57)

1. Leung DY, Boguniewicz M, and Howell MD. New insights into atopic dermatitis. J Clin Invest 113:651-657, 2004.
2. Shaker M. New insights into the allergic march. Curr Opin Pediatr 26:516-520, 2014.
3. Braback L, Hjern A, and Rasmussen F. Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non-farming environments. A nationwide study over three decades. Clin Exp Allergy 34:38-43, 2004.
4. DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc 33:227-234, 2012.
5. Bieber T. Atopic dermatitis. N Engl J Med 358:1483-1494, 2008.
6. Leung DY, and Bieber T. Atopic dermatitis. Lancet 361:151-160, 2003.
7. Lio PA, Lee M, LeBovidge J, et al. Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter 2012. J Allergy Clin Immunol Pract 2:361-369; quiz 370, 2014.
8. Totri CR, Diaz L, Eichenfield LF. 2014 update on atopic dermatitis in children. Curr Opin Pediatr 26:466-471, 2014.
9. Koulouri M, Vrachnou E, Liatsis E, et al. PD36 - Evaluation of intracellular cytokines IL-2, IFN7, IL-4 and IL-5 in children with atopic dermatitis and correlations with other immunological and epidemiological parameters. Clin Transl Allergy 28:4, 2014.
10. Ong PY, and Leung DY. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 6:384-389, 2006.
11. Grewe M, Bruijnzeel-Koomen CA, Schöpf E, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359-361, 1998.
12. Frieri M, Martinez S, Agarwal K, and Trotta P. A preliminary study of interleukin-4 detection in atopic pediatric and young adult patients. Pediatr Asthma Allergy Immunol 7:27-35, 1993.
13. Knapik M, and Frieri M. Altered cytokine production in atopic dermatitis. Pediatr Asthma Allergy Immunol 7:127-133, 1993.
14. Peng W, and Novak N. Recent developments in atopic dermatitis. Curr Opin Allergy Clin Immunol 14:417-22, 2014.
15. Raap U, Weißmantel S, Gehring M, et al. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol 23:285-288, 2012.
16. Schmid-Grendelmeier P, Simon D, and Simon HU. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 56:841-849, 2001.
17. Havstad S, Johnson CC, Kim H, et al. Atopic phenotypes identified with latent class analyses at age 2 years. J Allergy Clin Immunol 134:722-727.e2, 2014.
18. ETAC STUDY GROUP. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol 9:116-124, 1998.
19. Novembre E, Cianferoni A, Lombardi E, et al. Natural history of "intrinsic" atopic dermatitis. Allergy 56:452-453, 2001.
20. Wüthrich B, and Schmid-Grendelmeier P. Natural course of AEDS. Allergy 57:267-268, 2002.
21. Novak N, and Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112:252-262, 2003.
22. Aquino M, and Fonacier L. The role of contact dermatitis in patients with atopic dermatitis. J Allergy Clin Immunol Pract 2:382-387, 2014.
23. Leonardi S, Miraglia del Giudice M, and La Rosa M. Atopic disease, immune system, and the environment. Allergy Asthma Proc 28:410-417, 2007.
24. Miraglia del Giudice M, Decimo F, and Leonardi S. Immune dysregulation in atopic dermatitis. Allergy Asthma Proc 27:451-455, 2006.
25. Leonardi S, Rotolo N, and Vitaliti G IgE values and T-lymphocyte subsets in children with atopic eczema/dermatitis syndrome. Allergy Asthma Proc 28:529-534, 2007.
26. Hogan AD, and Burks AW. Epidermal Langerhans cells and their function in the skin immune system. Ann Allergy Asthma Immunol 71:5-10, 1995.
27. Souwer Y, Szegedi K, and Kapsenberg ML. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 22:821-826, 2010.
28. Ciprandi G, De Amici M, Giunta V, et al. Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol 30:222-225, 2013.
29. Koga C, Kabashima K, Shiraishi N, et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128: 2625-2630, 2008.
30. Souwer Y, Szegedi K, Kapsenberg ML, and de Jong EC. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 22:821-826, 2010.
31. Toda M, Leung DY, Molet S, et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111:875-881, 2003.
32. Kastelein RA, Hunter CA, and Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25:221-242, 2007.
33. Couper KN, Blount DG, and Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 180:5771-5777, 2008.
34. Simon D, Braathen LR, and Simon HU. Increased lipopolysaccharide-induced tumour necrosis factorα, interferon-γ and interleukin-10 production in atopic dermatitis. Br J Dermatol 157: 583-586, 2007.
35. Asadullah K, Sterry W, and Stephanek K. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 101:783-794, 1998.
36. Howell MD, Novak N, Bieber T, et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125:738-745, 2005.
37. Ohmen JD, Hanifin JM, and Nickoloff BJ. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154:1956-1963, 1995.
38. Aleksza M, Lukács A, Antal-Szalmás P, et al. Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis. Br J Dermatol 147:1135-1141, 2002.
39. Frieri M, Bennuri B, Dias C, et al. Association between CD62 ligand on naïve and memory T cells and history of cow's milk hypersensitivity in atopic patients. Ann Allergy Asthma Immunol 92:565-572, 2004.
40. Rajka G, and Langeland T. Grading of severity of atopic dermatitis. Acta Derm Venerol 144:13-14, 1989.
41. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 186:23-31, 1993.
42. Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test - European standards. Clin Transl Allergy 3:3, 2013.
43. Salpietro C, Rigoli L, Miraglia Del Giudice M, et al. Int J TLR2 and TLR4 gene polymorphisms and atopic dermatitis in Italian children: a multicenter study. Immunopathol Pharmacol 24:33-40, 2011.
44. Fuiano N, Delvecchio M, and Incorvaia C. Factors associated with different results of allergy tests in children with dust mite-induced atopic dermatitis. Allergol Immunopathol (Madr) S0301-0546(14)00093-7, 2014.
45. Banerjee S, Resch Y, Chen KW, et al. Der p 11 is a major allergen for house dust mite allergic patients suffering from atopic dermatitis. J Invest Dermatol 2014. doi: 10.1038/jid.2014.271. [Epub ahead of print]
46. Zhu S, and Qian Y. 17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond) 122:487-511, 2012.
47. Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123:1244-1252, 2009.
48. Ciprandi G, Cuppari C, and Salpietro A. Serum IL-23 strongly and inversely correlates with FEV1 in asthmatic children. Int Arch Allergy Immunol 159:183-186, 2012.
49. Ciprandi G, Cuppari C, and Salpietro C. Serum IL-23: a surrogate biomarker for asthma? Clin Exp Allergy 42:1416-1417; author reply 1418, 2012.
50. Vitaliti G, Leonardi S, Miraglia Del Giudice M, et al. Mucosal immunity and sublingual immunotherapy in respiratory disorders. J Biol Regul Homeost Agents 26:85-93, 2012.
51. Sabat R, Grütz G, Warszawska K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev 21:331-344, 2010.
52. Simon D, Braathen LR, and Simon HU. Increased lipopolysaccharide-induced tumour necrosis factor-α, interferon-γ and interleukin-10 production in atopic dermatitis. Br J Dermatol 157: 583-586, 2007.
53. Darling AR, Freyschmidt EJ, Burton OT, et al. L-10 suppresses IL-17-mediated dermal inflammation and reduces the systemic burden of Vaccinia virus in a mouse model of eczema vaccinatum. Clin Immunol 150:153-60, 2014.
54. Niwa Y. Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 136:125-126, 2000.
55. Shen CY, Lin MC, Lin HK, et al. The natural course of eczema from birth to age 7 years and the association with asthma and allergic rhinitis: a population-based birth cohort study. Allergy Asthma Proc 34:78-83, 2013.
56. Wollenberg A, and Bieber T. Atopic dermatitis: from the genes to skin lesions. Allergy 55:205-213, 2000.
57. Cuppari C, Leonardi S, Manti S, et al. Allergen immunotherapy, routes of administration and cytokine networks: an update. Immunotherapy 6:775-786, 2014.